Categories: India

BRIEF-Nucana Says Data From Nutide:701 Shows Favorable Safety And Tumor Reduction

Oct 18 (Reuters) – NuCana PLC: * NUCANA PRESENTS ENCOURAGING DATA ON NUC-7738 IN COMBINATION WITH PD-1 INHIBITORS USING PRIMARY PATIENT-DERIVED ORGANOIDS AND AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AT THE ESMO CONGRESS 2025 * NUCANA PLC – REGULATORS APPROVE STUDY EXPANSION FOR 28 MORE PATIENTS * NUCANA PLC – DATA TO DATE FROM NUTIDE:701 SHOWS FAVORABLE SAFETY AND TUMOR REDUCTION Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

How Trump and Xi went from tariff war to trade truce

SHENZHEN, China, Nov 17 (Reuters) - Chinese leader Xi Jinping is due to meet US…

27 seconds ago

Exclusive-China taps US AI models to train homegrown rivals as chip curbs bite

By Eduardo Baptista and Laurie Chen BEIJING, Nov 17 (Reuters) - Chinese entities are adopting…

1 minute ago

Australian dollar hits 10-month low; kiwi hovers near 2009 crisis-era levels

SYDNEY, Nov 17 (Reuters) - The Australian dollar weakened to a 10-month low on Tuesday…

5 minutes ago

US releases details on criminal probe of Megaspeed, says investigation initiated in 2024

WASHINGTON, Nov 16 (Reuters) - The US Commerce and Justice Departments released information on Monday…

8 minutes ago

Exclusive-China taps US AI models to train homegrown rivals as chip curbs bite

By Eduardo Baptista and Laurie Chen BEIJING, Nov 17 (Reuters) - Chinese entities are adopting…

11 minutes ago

Exclusive-China taps US AI models to train homegrown rivals as chip curbs bite

By Eduardo Baptista and Laurie Chen BEIJING, Nov 17 (Reuters) - Chinese entities are adopting…

12 minutes ago